Ozempic and Heart Disease

Y POINTS

• The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk’s #Wegovy weight loss drug to reduce the risk of #overweight and #obese adults suffering from serious #heartproblems or #strokes.

• It follows similar label expansion by the U.S. Food and Drug Administration in March.